ArticleACS applied materials & interfaces2026
Probing Glycan-Gold Nanoparticle Architectures: Glycan Type, Density, and Linker Length, Governing Multivalent Lectin Binding and Viral Inhibition.
Article in ACS applied materials & interfaces, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multivalent lectin-glycan interactions (MLGIs) are widespread and vital for pathogen infection, cell-cell communication, and immune regulation, making them attractive therapeutic targets. Despite significant efforts, research progress in MLGI targeting therapeutics remains limited, due to our incomplete understanding of the structural and biophysical mechanisms of some key MLGIs, which has hampered the design of spatially matched multivalent therapeutics. Moreover, the overlapping glycan specificities of various lectins make it difficult to target MLGIs with high potency and selectivity. To address this challenge, we have recently developed polyvalent glycan nanoparticles (glycan-NPs) as biophysical probes for MLGIs. The NPs' unique, size-dependent optical properties are exploited as sensitive readouts for quantifying MLGI affinities and thermodynamics, while their nanoscale size and high electron microscopy contrast are exploited for probing binding modes and binding site orientation. Despite this success, how design features such as glycan type, density, and linker flexibility govern glycan-NP MLGI properties remains underexplored. In this work, we coated gold nanoparticles (GNPs) with varying densities of a lipoic acid-oligo(ethylene glycol)-α-manno-α-1,2-biose (DiMan) or fucose (Fuc) ligand of varying linker lengths and studied their MLGIs with DC-SIGN, an important tetrameric lectin viral receptor found on dendritic cells. Using our recently established GNP fluorescence quenching assay, we reveal that displaying DiMan or Fuc polyvalently on a GNP surface greatly enhances their DC-SIGN affinity, with low nanomolar apparent
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.